Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

National Health Investors, Inc. Common Stock (NY:NHI)

75.77 +0.46 (+0.61%)
Official Closing Price Updated: 7:00 PM EDT, Apr 17, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about National Health Investors, Inc. Common Stock

< Previous 1 2 3 4 5 6 Next >
NHI Announces Third Quarter 2024 Dividend
Via ACCESSWIRE
NHI Issues Investor Update
Via ACCESSWIRE
NHI Announces Second Quarter 2024 Results
Via ACCESSWIRE
NHI Announces Second Quarter 2024 Earnings Release and Conference Call Date
Via ACCESSWIRE
What Analysts Are Saying About National Health Investors Stock
Via Benzinga
NHI Files Supplemental Proxy
Via ACCESSWIRE
NHI Stock Earnings: National Health Investors Reported Results for Q1 2024
National Health Investors just reported results for the first quarter of 2024. 
Via InvestorPlace
NHI Issues Investor Update
Via ACCESSWIRE
NHI Announces Second Quarter 2024 Dividend
Via ACCESSWIRE
NHI Announces First Quarter 2024 Results
Via ACCESSWIRE
NHI Announces First Quarter 2024 Earnings Release and Conference Call Date
Via ACCESSWIRE
Deep Dive Into National Health Investors Stock: Analyst Perspectives (6 Ratings)
Via Benzinga
The 7 Most Undervalued REITs to Buy in April 2024
Uncover seven REITs with compelling valuations and high-income potential, ready to enhance your portfolio this April. 
Via InvestorPlace
Wall Street's Most Accurate Analysts Say Hold These 3 Real Estate Stocks With Over 4% Dividend Yields
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high... 
Via Benzinga
Senior Housing Sector Is Reviving, Analyst Forecasts Growth For National Health Investors
BMO Capital Markets upgrades National Health Investors to Outperform, citing potential for multiple expansions, SHOP growth, and acquisitions. 
Via Benzinga
Beyond The Numbers: 4 Analysts Discuss National Health Investors Stock
Via Benzinga
NHI Issues Investor Update
Via ACCESSWIRE
NHI Announces First Quarter 2024 Dividend
Via ACCESSWIRE
Analysts See Upside On These 3 REITs
Via Benzinga
Block To Rally More Than 20%? Here Are 10 Top Analyst Forecasts For Monday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. 
Via Benzinga
NHI Announces Fourth Quarter 2023 Results
Via ACCESSWIRE
Analyst Initiates Coverage On 10 Healthcare REITs, But Which Ones Are Buys?
Via Benzinga
NHI Announces Fourth Quarter 2023 Earnings Release and Conference Call Date
Via ACCESSWIRE
Where National Health Investors Stands With Analysts
Via Benzinga
NHI Issues Investor Update
Via ACCESSWIRE
NHI Announces Third Quarter 2023 Results
Via ACCESSWIRE
Earnings Scheduled For February 20, 2024
Companies Reporting Before The Bell • Barclays (NYSE:BCS) is likely to report quarterly earnings at $0.36 per share on revenue of $7.38 billion. 
Via Benzinga
The 7 Best REITs to Buy in January 2024
It's not only the prospect of lower interest rates that makes these seven real estate plays the best REITs for 2024. 
Via InvestorPlace
Check Out 3 Real Estate Stocks With Over 6% Dividend Yields From Wall Street's Most Accurate Analysts
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high... 
Via Benzinga
7 Elder Care Stocks to Take Advantage of Aging America
Buy these seven elder care stocks, as each one has ample exposure to the long-term "graying of America" trend. 
Via InvestorPlace
< Previous 1 2 3 4 5 6 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.